Companies / Trillium Therapeutics Inc.
Trillium Therapeutics Inc.
TRILCIK 1616212
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 11, 2021 | Skvarka Jan CEO | Sell Open-market sale | Common Shares | $981.8K | -107K -100.00% | 0 | medium |
| Jan 14, 2021 | Skvarka Jan CEO | Sell Open-market sale | Common Shares | $294.3K | -20K -100.00% | 0 | medium |
| May 12, 2021 | Skvarka Jan CEO | Sell Open-market sale | Common Shares | $219.9K | -24K -100.00% | 0 | medium |
| Jan 8, 2021 | Parsons James T. Executive | Sell Open-market sale | Common Shares | $134.3K | -9K -100.00% | 0 | medium |
| Jan 8, 2021 | Uger Robert Executive | Sell Open-market sale | Common Shares | $88.6K | -6K -100.00% | 0 | low |
| Feb 8, 2021 | Uger Robert Executive | Sell Open-market sale | Common Shares | $83.0K | -7K -100.00% | 0 | low |
| Jan 13, 2021 | Skvarka Jan CEO | Sell Open-market sale | Common Shares | $81.5K | -5K -100.00% | 0 | low |
| Feb 8, 2021 | Petrova Penka Executive | Sell Open-market sale | Common Shares | $67.2K | -5K -100.00% | 0 | low |